Case report: reuse of tirofiban leads to very severe thrombocytopenia

Case report: reuse of tirofiban leads to very severe thrombocytopenia

BackgroundTelofiban is a class of small molecule non-peptide tyrosine derivatives containing RGD sequences. It is the only platelet surface glycoprotein (GP) IIb/IIIa receptor antagonist (GPI) currently marketed in China. In patients with ST-segment elevation myocardial infarction(STEMI) who receive...

Full description

Bibliographic Details
Main Authors: Yuqing Li, Jiuchun Qiu, Yi Gao, Guangping Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
tirofiban
thrombocytopenia
severe
anaphylaxis
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130552/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130552/full

Similar Items